Electrolyte Beverage Combined With Polyethylene Glycol for Colonoscopy Bowel Preparation
Randomized Controlled Trial of Different Ratios of Electrolyte Beverage and Water Combined With Polyethylene Glycol on Bowel Preparation Quality and Ingestion Rhythm Before Colonoscopy
1 other identifier
interventional
405
1 country
1
Brief Summary
This randomized controlled trial aims to evaluate the effects of different ratios of electrolyte beverage and water combined with polyethylene glycol (PEG) on bowel preparation quality before colonoscopy. Participants undergoing elective colonoscopy will be randomly assigned to one of three bowel preparation regimens: PEG prepared with water only, PEG prepared with a low ratio of electrolyte beverage and water, or PEG prepared with a medium ratio of electrolyte beverage and water. The primary outcome is adequate bowel preparation assessed by the Boston Bowel Preparation Scale (BBPS). Secondary outcomes include bowel preparation completion rate, tolerability, adverse events, repeat colonoscopy rate, adenoma detection rate, and ingestion rhythm characteristics during bowel preparation. This study also aims to explore whether electrolyte beverage-assisted bowel preparation may improve bowel cleansing quality by influencing participants' ingestion rhythm and adherence during PEG intake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2026
CompletedStudy Start
First participant enrolled
May 18, 2026
CompletedFirst Posted
Study publicly available on registry
May 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2027
May 27, 2026
May 1, 2026
9 months
May 18, 2026
May 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Adequate Bowel Preparation Rate
Adequate bowel preparation is defined as a total Boston Bowel Preparation Scale (BBPS) score ≥6 with each colonic segment score ≥2 during colonoscopy.
At the time of colonoscopy on Day 1
Secondary Outcomes (3)
Total Boston Bowel Preparation Scale Score
At the time of colonoscopy on Day 1
Bowel Preparation Completion Rate
During bowel preparation within 1 hour before colonoscopy on Day 1
Adverse Event Rate
During bowel preparation within 1 hour before colonoscopy on Day 1
Study Arms (3)
Water Group
ACTIVE COMPARATORParticipants receive polyethylene glycol (PEG) prepared with water only for bowel preparation before colonoscopy.
Low-dose Electrolyte Beverage Group
EXPERIMENTALParticipants receive polyethylene glycol (PEG) prepared with electrolyte beverage and water at a 1:3 ratio for bowel preparation before colonoscopy.
Medium-dose Electrolyte Beverage Group
EXPERIMENTALParticipants receive polyethylene glycol (PEG) prepared with electrolyte beverage and water at a 1:1 ratio for bowel preparation before colonoscopy.
Interventions
Polyethylene glycol (PEG) prepared with water only for bowel preparation before colonoscopy.
Polyethylene glycol (PEG) prepared with electrolyte beverage and water at a 1:3 ratio for bowel preparation before colonoscopy.
Polyethylene glycol (PEG) prepared with electrolyte beverage and water at a 1:1 ratio for bowel preparation before colonoscopy.
Eligibility Criteria
You may qualify if:
- Adults aged 18-75 years scheduled to undergo elective colonoscopy
- Meet the standard clinical indications for colonoscopy;
- Able to understand and comply with the bowel preparation procedure and complete oral polyethylene glycol (PEG) intake as required;
- Able to comply with study-related data collection and follow-up;
- Provide written informed consent voluntarily.
You may not qualify if:
- Previously diagnosed colorectal cancer, intestinal obstruction, or suspected intestinal obstruction;
- Active gastrointestinal bleeding or a definite history of gastrointestinal bleeding within the past 4 weeks (including melena, hematochezia, or hematemesis);
- Severe renal insufficiency, decompensated heart failure, significant electrolyte imbalance, or other conditions unsuitable for PEG bowel preparation;
- Known allergy to polyethylene glycol or components of the electrolyte beverage used in the study;
- Pregnant or breastfeeding women;
- Any other condition considered by the investigators to make the participant unsuitable for the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 18, 2026
First Posted
May 27, 2026
Study Start
May 18, 2026
Primary Completion (Estimated)
January 31, 2027
Study Completion (Estimated)
May 31, 2027
Last Updated
May 27, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share